膜磷脂重塑通过调节线粒体稳态调控非酒精性脂肪性肝炎进展
本研究分析人NASH肝组织中LPCAT3表达及其与疾病严重程度的相关性,并利用Lpcat3肝脏特异性敲除小鼠、RNA测序、脂质组学和代谢组学等方法,发现LPCAT3在人类NASH肝脏中显著抑制,其缺失促进小鼠自发和饮食诱导的NASH/HCC,机制涉及线粒体稳态受损,过表达Lpcat3可改善NASH炎症和纤维化。
要点
- LPCAT3在人类NASH肝脏中显著抑制,其表达与NAFLD活动评分和纤维化分期呈负相关。
- Lpcat3肝脏缺失促进小鼠自发和饮食诱导的NASH/HCC,与活性氧产生增加和线粒体稳态受损相关。
- 肝脏过表达Lpcat3可改善NASH的炎症和纤维化。
核心结论
- 膜磷脂组成调控NASH进展,操纵LPCAT3表达可能是NASH的有效治疗手段。
研究设计与样本
- 分析人类NASH患者样本中LPCAT3表达及其与NASH严重程度的相关性。
- 使用Lpcat3肝脏特异性敲除(LKO)小鼠研究Lpcat3缺失对NASH进展的影响。
- 对肝脏样本进行RNA测序、脂质组学和代谢组学分析。
- 使用原代肝细胞和肝细胞系进行体外分析。
主要发现
- LPCAT3在人类NASH肝脏中显著抑制,其表达与NAFLD活动评分和纤维化分期呈负相关。
- 小鼠肝脏Lpcat3缺失促进自发和饮食诱导的NASH/HCC。
- Lpcat3缺陷因线粒体稳态受损而增强活性氧产生。
- Lpcat3缺失增加线粒体内膜磷脂饱和度并升高应激诱导的自噬,导致线粒体含量减少和碎片化增加。
- 肝脏过表达Lpcat3可改善NASH的炎症和纤维化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: NASH, characterized by inflammation and fibrosis, is emerging as a leading etiology of HCC. Lipidomics analyses in the liver have shown that the levels of polyunsaturated phosphatidylcholine (PC) are decreased in patients with NASH, but the roles of membrane PC composition in the pathogenesis of NASH have not been investigated. Lysophosphatidylcholine acyltransferase 3 (LPCAT3), a phospholipid (PL) remodeling enzyme that produces polyunsaturated PLs, is a major determinant of membrane PC content in the liver. APPROACH AND RESULTS: The expression of LPCAT3 and the correlation between its expression and NASH severity were analyzed in human patient samples. We examined the effect of Lpcat3 deficiency on NASH progression using Lpcat3 liver-specific knockout (LKO) mice. RNA sequencing, lipidomics, and metabolomics were performed in liver samples. Primary hepatocytes and hepatic cell lines were used for in vitro analyses. We showed that LPCAT3 was dramatically suppressed in human NASH livers, and its expression was inversely correlated with NAFLD activity score and fibrosis stage. Loss of Lpcat3 in mouse liver promotes both spontaneous and diet-induced NASH/HCC. Mechanistically, Lpcat3 deficiency enhances reactive oxygen species production due to impaired mitochondrial homeostasis. Loss of Lpcat3 increases inner mitochondrial membrane PL saturation and elevates stress-induced autophagy, resulting in reduced mitochondrial content and increased fragmentation. Furthermore, overexpression of Lpcat3 in the liver ameliorates inflammation and fibrosis of NASH. CONCLUSIONS: These results demonstrate that membrane PL composition modulates the progression of NASH and that manipulating LPCAT3 expression could be an effective therapeutic for NASH.
引用
- Tian Y, Jellinek MJ, Mehta K, et al. Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis. Hepatology. 2023. PMID: 36999536. doi:10.1097/HEP.0000000000000375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。